Related Experiment Video
Updated: Jan 1, 2026

Patient Derived Cell Culture and Isolation of CD133+ Putative Cancer Stem Cells from Melanoma
Published on: March 13, 2013
Accumulation of CD103+ CD8+ T cells in a cutaneous melanoma micrometastasis
Katharina Hochheiser1,2, Han Xian Aw Yeang1,3, Teagan Wagner2,4
1Peter MacCallum Cancer Centre Melbourne VIC Australia.
Objective:
The immune system can halt cancer progression by suppressing outgrowth of clinically occult micrometastases in a state of cancer-immune equilibrium. Cutaneous melanoma provides a unique opportunity to study the immune contexture of such lesions, as miniscule skin metastases are accessible to clinical inspection and diagnostic biopsy.
Methods:
Here, we analysed by multiplex immunofluorescence microscopy samples from a melanoma patient presenting with an overt and an occult in-transit metastasis (ITM), the latter of which appeared as a small erythematous papule.
Results:
Microarchitecture and immune composition in the two lesions were vastly different. CD4+ and CD8+ T cells accumulated around the margin of the overt SOX10+ Melan A+ ITM but were largely excluded from the tumor centre. By contrast, the occult micrometastasis contained only few SOX10+ Melan A- melanoma cells which were scattered within a dense infiltrate of T cells, including a prominent population of CD103+ CD8+ T cells resembling tissue-resident memory T (TRM) cells. Notably, almost every single melanoma cell in the micrometastasis was in close proximity to these TRM-like cells.
Conclusion:
Such results support the emerging concept that CD103+ CD8+ TRM cells are key mediators of cancer surveillance and imply an important function of these cells in controlling clinically occult micrometastases in humans.
Insights
Tissue-resident memory T (TRM) cells, specifically CD103+ CD8+ TRM cells, are crucial for controlling occult melanoma micrometastases. These cells surround and likely eliminate early-stage cancer cells, highlighting their role in immune surveillance.
Area of Science:
- Immunology
- Dermatology
- Oncology
Background:
- The immune system can prevent cancer progression by controlling small, undetectable metastases.
- Cutaneous melanoma offers a model to study the immune environment of these early-stage lesions.
Observation:
- A patient with melanoma presented with both an overt and an occult in-transit metastasis (ITM).
- Multiplex immunofluorescence microscopy was used to analyze the immune composition of both lesions.
Findings:
- The overt ITM showed T cells at the tumor margin, excluding the center.
- The occult micrometastasis had few melanoma cells scattered within a dense T cell infiltrate.
- A significant population of CD103+ CD8+ T cells, resembling tissue-resident memory T (TRM) cells, were found in the occult lesion, closely interacting with melanoma cells.
Implications:
- CD103+ CD8+ TRM cells are key mediators of cancer immune surveillance.
- These TRM cells play a critical role in controlling clinically occult micrometastases in humans.
More Related Videos
09:57Real Time Detection of In Vitro Tumor Cell Apoptosis Induced by CD8+ T Cells to Study Immune Suppressive Functions of Tumor-infiltrating Myeloid Cells
Published on: January 29, 2019
07:45Author Spotlight: A Model to Study the Systemic and Local Dynamics of CD8+ T Cells During LN Metastasis
Published on: January 26, 2024